Comments on AASLD Practice Guidelines for Alcoholic Liver Disease Reply

被引:0
|
作者
McCullough, Arthur [1 ]
Dasarathy, Srinivasan [1 ]
O'Shea, Robert [1 ]
机构
[1] Cleveland Clin Fdn, Dept Gastroenterol & Hepatol, Cleveland, OH 44195 USA
关键词
D O I
10.1002/hep.23652
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:1861 / 1861
页数:1
相关论文
共 50 条
  • [41] Practice and guidelines - Reply
    Young, PC
    PEDIATRICS, 1996, 97 (04) : 605 - 605
  • [42] PRACTICE GUIDELINES - REPLY
    BROOK, RH
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1990, 263 (22): : 3022 - 3022
  • [43] BIOLOGIC MARKERS OF ALCOHOLISM IN ALCOHOLIC LIVER-DISEASE - REPLY
    AUBA, J
    SERRANO, M
    FRUTOS, D
    MIRA, M
    MEDICINA CLINICA, 1993, 101 (09): : 358 - 358
  • [44] Distinguishing nonalcoholic fatty liver disease from alcoholic liver disease: Is ANI enough? Reply
    Dunn, Winston
    Angulo, Paul
    Sanderson, Schuyler O.
    Kamath, Patrick S.
    Shah, Vrjay
    GASTROENTEROLOGY, 2007, 132 (05) : 2077 - 2078
  • [45] Wilson disease: a summary of the updated AASLD Practice Guidance
    Alkhouri, Naim
    Gonzalez-Peralta, Regino P.
    Medici, Valentina
    HEPATOLOGY COMMUNICATIONS, 2023, 7 (06)
  • [46] Non-alcoholic fatty liver disease guidelines: An Asian perspective
    Ishii, Hiromasa
    Kajihara, Mikio
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 (06) : 769 - 770
  • [47] EVOLVING PARADIGM OF GUIDELINES FOR NON-ALCOHOLIC FATTY LIVER DISEASE
    Lacatusu, Cristina Mihaela
    Grigorescu, Elena Daniela
    Onofriescu, Alina
    Popa, Alina Delia
    Popescu, Raluca Maria
    Botnariu, Gina Eosefina
    Mihai, Bogdan Mircea
    INTERDIAB 2017: DIABETES MELLITUS IN INTERNAL MEDICINE, 2017, : 39 - 48
  • [48] Screening in liver disease: Report of an AASLD Clinical Workshop
    Adams, PC
    Arthur, MJ
    Boyer, TD
    DeLeve, LD
    Di Bisceghe, AM
    Hall, M
    Levin, TR
    Provenzale, D
    Seeff, L
    HEPATOLOGY, 2004, 39 (05) : 1204 - 1212
  • [49] EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease: disease mongering or call to action?
    Elisabetta Bugianesi
    Diabetologia, 2016, 59 : 1145 - 1147
  • [50] Comments on the 2021 ESC guidelines on cardiovascular disease prevention in clinical practice
    Arrarte, Vicente
    Campuzano, Raquel
    Duque, Jose Antonio Alarcon
    Aldama, Guillermo
    Barrios, Vivencio
    Bonanad, Clara
    Conde, Almudena Castro
    Olmo, Rosa Fernandez
    Gamez, Jose M.
    Guzman-Martinez, Gabriela
    Rey, Carmen Neiro
    Vivas, David
    Avanzas, Pablo
    Congost, Gemma Berga
    Boraita, Araceli
    Bueno, Hector
    Calvo, David
    Delgado, Victoria
    Dos, Laura
    Ferreira-Gonzalez, Ignacio
    Doblas, Juan Jose Gomez
    Figal, Domingo Pascual
    Sambola, Antonia
    Tejedor, Ana Viana
    Ferreiro, Jose Luis
    Alfonso, Fernando
    REVISTA ESPANOLA DE CARDIOLOGIA, 2022, 75 (05): : 364 - 369